Search Results

Chris Toth

Chris Toth is executive vice president and group president, Kidney Care. Toth assumed his responsibilities at Baxter in June 2023 and has been selected as the chief executive officer of the company's proposed spinoff of its Kidney Care business into an independent, publicly traded company.

​Cathy R. Smith

Cathy R. Smith has served as a director of Baxter since July 2017.

James Borzi

James Borzi is executive vice president, chief supply chain officer. Borzi joined Baxter in August 2020 from GE Healthcare, where he served as vice president, chief supply chain officer from 2019 to 2020. Prior to joining GE Healthcare, he spent five years with Becton Dickinson (BD) in various manufacturing operations leadership roles; his last role with BD was executive vice president of Global Operations and chief supply chain officer.

William A. Ampofo II

William A. Ampofo II has served as a director of Baxter since June 2023. 

​Jeanne Mason, Ph.D.

Jeanne Mason, Ph.D. is executive vice president and chief human resources officer.

David S. Rosenbloom

David S. Rosenbloom is executive vice president and general counsel. Rosenbloom joined Baxter in 2022 from McDermott Will & Emery, where he served as a partner for 24 years and global head of the Litigation Practice Group from 2017-2022. Prior to McDermott, he served for eight years in the U.S. Attorney’s Office for the Northern District of Illinois.

​Stephen N. Oesterle, M.D.

Stephen N. Oesterle, M.D. has served as a director of Baxter since February 2017.

Stephen H. Rusckowski

Steve Rusckowski has served as a director of Baxter since August 2023.

Gerard (Jerry) Greco, Ph.D.

Gerard (Jerry) Greco, Ph.D., is senior vice president, chief quality officer. Greco joined Baxter in 2023 from Takeda Pharmaceuticals, where he most recently served as the global quality officer, leading all quality and quality compliance for the company. During his 35-plus years in the healthcare industry, he has served in quality roles of increasing responsibility at Teva Pharmaceuticals, Pfizer, Wyeth Pharmaceuticals and Johnson & Johnson.

Tobi Karchmer, M.D., M.S.

Tobi Karchmer, M.D., M.S., is senior vice president and chief medical and scientific officer. Prior to her appointment to chief medical officer in 2021, Karchmer served as vice president, Worldwide Medical, which consists of Baxter's Global and Regional Medical Affairs teams, Clinical Research team and Strategy and Delivery team.